PDPL

Parenteral Drugs (India) Share PriceParenteral Drugs (India)

₹3.8
-0.2 (-5%)
As on 22 March, 2023 | 04:53 BSE: 524689 NSE: PDPL

Parenteral Drugs (India) Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Parenteral Drugs (India)

Start SIP

Parenteral Drugs (India) Share Price

  • Over 1 Month -5%
  • Over 3 Month -10.59%
  • Over 6 Month 20.63%
  • Over 1 Year -2.56%

Parenteral Drugs (India) Key Statistics

P/E Ratio -0.1
PEG Ratio -0
Market Cap Cr 11
Price to Book Ratio -0
EPS -43.1
Dividend 0
Relative Strength Index 46.4
Money Flow Index 54.21
MACD Signal 0.13
Average True Range 0.17

Parenteral Drugs (India) Investment Rating

  • Master Rating:
  • Parenteral Drugs India Susp - Susp.17/02/2023 has an operating revenue of Rs. 8.50 Cr. on a trailing 12-month basis. An annual revenue de-growth of -30% needs improvement, Pre-tax margin of -1284% needs improvement, NULL It is currently FORMING a base in its weekly chart and is trading around 20% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 44 which is a POOR score indicating inconsistency in earnings, a RS Rating of 0 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 88 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

EPS Strength

Price Strength

N/A

Buyer Demand

Group Rank

Parenteral Drugs (India) Financials
IndicatorMar 2022
Oper Rev Qtr Cr 2
Operating Expenses Qtr Cr 8
Operating Profit Qtr Cr -6
Depreciation Qtr Cr 27
Interest Qtr Cr 0
Tax Qtr Cr -5
Net Profit Qtr Cr 24

Parenteral Drugs (India) Technicals

EMA & SMA

Current Price
₹3.8
-0.2 (-5%)
  • Bullish Moving Average
  • ___
  • 5
  • Bearish Moving Average
  • ___
  • 11
  • 20 Day
  • 3.99
  • 50 Day
  • 3.82
  • 100 Day
  • 3.7
  • 200 Day
  • 3.82
  • 20 Day
  • 4.13
  • 50 Day
  • 3.76
  • 100 Day
  • 3.71
  • 200 Day
  • 3.5

Parenteral Drugs (India) Resistance and Support

PIVOT
₹4.
Resistance
First Resistance 4
Second Resistance 4
Third Resistance 4
RSI 46.4
MFI 54.21
MACD Single Line 0.13
MACD 0.08
Support
First Resistance 4
Second Resistance 4
Third Resistance 4

Parenteral Drugs (India) Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 3,625 362,500 100
Week
1 Month
6 Month 1,557 155,732 100

Parenteral Drugs (India) Result Highlights

Parenteral Drugs (India) Synopsis

NSE-Medical-Diversified

Parenteral Drugs is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 12.17 Cr. and Equity Capital is Rs. 29.82 Cr. for the Year ended 31/03/2021. Parenteral Drugs (India) Ltd. is a Public Limited Listed company incorporated on 13/12/1983 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24100MH1983PLC126481 and registration number is 126481.
Market Cap 11
Sales 8
Shares in Float 0.81
No of funds
Yield
Book Value -0.02
U/D Vol ratio 2.2
LTDebt / Equity
Alpha 0.09
Beta 0.05

Parenteral Drugs (India)

Owner NameMar-22
Promoters 73.29%
Mutual Funds 0.01%
Financial Institutions/ Banks
Individual Investors 21.74%
Others 4.96%

Parenteral Drugs (India) Management

Name Designation
Mr. Manohar Lal Gupta Chairman & Non-Exe.Director
Mr. Vinod Kumar Gupta Managing Director & CFO
Mr. Govind Das Garg Whole Time Director
Mr. Dharam Pal Khanna Ind. Non-Executive Director
Mr. Dilip Kumar Sinha Ind. Non-Executive Director
Mrs. Deepali Garhewal Ind. Non-Executive Director
Mr. Manish Verma Ind. Non-Executive Director
Mr. Anil Mittal Non Executive Director

Parenteral Drugs (India) Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Parenteral Drugs (India) FAQs

What is Share Price of Parenteral Drugs (India) ?

Parenteral Drugs (India) share price is ₹3 As on 22 March, 2023 | 04:39

What is the Market Cap of Parenteral Drugs (India) ?

The Market Cap of Parenteral Drugs (India) is ₹11.3 Cr As on 22 March, 2023 | 04:39

What is the P/E ratio of Parenteral Drugs (India) ?

The P/E ratio of Parenteral Drugs (India) is -0.1 As on 22 March, 2023 | 04:39

What is the PB ratio of Parenteral Drugs (India) ?

The PB ratio of Parenteral Drugs (India) is -0 As on 22 March, 2023 | 04:39

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number